Results 91 to 100 of about 174 (111)

Experiences in the care of Indigenous people in hospital settings: challenges for clinical management. [PDF]

Rev Bras Enferm
Duarte AVN, Mendes VA, Silva CGD, Ribeiro MRR, Ferreira GE.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease

Frontiers in Cardiovascular Medicine, 2021
Gael B Morrow, Claire S Whyte, Nicola J Mutch   +2 more
exaly  

Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism – a meta-analysis and systematic review

Vasa - European Journal of Vascular Medicine, 2020
Qiang Zhang, Mingfang Xu
exaly  

PAI-1 and the Metabolic Syndrome

Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
Marie-Christine Alessi, Irène Juhan-Vague   +1 more
exaly  

Five Frequent Polymorphisms of the PAI-1 Gene

Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
Marie-Christine Alessi, Franck Peiretti, D Arveiler   +2 more
exaly  

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Diabetologia, 2001
Marie-Christine Alessi, M Stegnar, Juhan-Vague I   +2 more
exaly  

Synthesis of a novel poly(amide-imide) (PAI) and preparation and characterization of PAI blended polyethersulfone (PES) membranes

Journal of Membrane Science, 2008
A Rahimpour, Shahram Mehdipour-Ataei
exaly  

A pore-controllable polyamine (PAI) layer-coated polyolefin (PE) separator for pouch lithium-ion batteries with enhanced safety

Journal of Solid State Electrochemistry, 2020
Jiahui Chen, Peipei Pang, Junmin Nan
exaly  

Modulation of Adipose Tissue Development by Pharmacological Inhibition of PAI-1

Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
David L Crandall, Irène Juhan-Vague, Marie-Christine Alessi   +2 more
exaly  

The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population

Diabetes, Obesity and Metabolism, 2007
Cristina Fernández-Pérez, M Serrano-Rios   +1 more
exaly